NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Cost of Revenue (2015 - 2026)

NextPlat's (NXPL) quarterly Cost of Revenue came in at $7.2 million in Q2 2026, down 30.61% year-over-year from $10.4 million in Q2 2025, and up 11.55% quarter-over-quarter from $6.4 million in Q1 2026.

Analysis

NextPlat (NXPL) Cost of Revenue (2015 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Cost of Revenue for 12 consecutive years, with $7.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cost of Revenue fell 30.61% year-over-year to $7.2 million in Q2 2026; TTM through Jun 2026 was $35.6 million, a 23.76% decrease from a year earlier, with the FY2025 full-year figure at $43.4 million, down 11.53% from the prior year.
  • Cost of Revenue was $7.2 million for Q2 2026 at NextPlat, up from $6.4 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $13.5 million in Q4 2024 and troughed at $2.0 million in Q3 2022.
  • A 5-year average of $7.9 million and a median of $10.5 million in 2023 frame the typical range for Cost of Revenue.
  • Across the five-year window, Cost of Revenue jumped 460.09% in 2024 and slumped 41.76% in 2026, its largest moves.
  • Over 5 years, Cost of Revenue stood at $2.2 million in 2022, then soared by 419.66% to $11.4 million in 2023, then climbed by 18.76% to $13.5 million in 2024, then declined by 18.73% to $11.0 million in 2025, then slumped by 34.51% to $7.2 million in 2026.
  • The last three Cost of Revenue figures came in at $7.2 million (Q2 2026), $6.4 million (Q1 2026), and $11.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 1.99 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 2.30 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 455.94 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 461.69 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 753.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 100.16 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 52.20 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 90.43 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 721,000.00
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 7.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.19 Mn
Mar 31, 2026 6.44 Mn
Dec 31, 2025 10.98 Mn
Sep 30, 2025 11.02 Mn
Jun 30, 2025 10.36 Mn
Mar 31, 2025 11.06 Mn
Dec 31, 2024 13.50 Mn
Sep 30, 2024 11.81 Mn
Jun 30, 2024 11.13 Mn
Mar 31, 2024 12.63 Mn
Dec 31, 2023 11.37 Mn
Sep 30, 2023 10.71 Mn
Jun 30, 2023 2.11 Mn
Mar 31, 2023 2.26 Mn
Dec 31, 2022 2.19 Mn
Sep 30, 2022 1.95 Mn
Jun 30, 2022 2.30 Mn
Mar 31, 2022 2.78 Mn
Dec 31, 2021 1.68 Mn
Sep 30, 2021 1.76 Mn